Frans Dirven
Oliver Duran
Yan Hua (Cici) Guo
During the last fifty years or so, disease control in the pork industry has evolved mainly relying on antimicrobials, vaccines, elimination (depopulation, repopulation, eradication, modified early weaning), and/or regional control depending on the diseases of concern and resources available. Looking forward, it is clear that antimicrobial usage, under increasing scrutiny for both metaphylactic and therapeutic uses will decline, whereas the use of vaccines will likely rise.
We live a world which is undergoing significant change. Never in the history of life on the planet has there been more demand for the transformation of the Earth’s scarce raw materials into consumer goods for people around the globe. The world is being reorganized to facilitate the globalization of both demand and production, so the desires of people next door and in the farthest reaches of the planet can be communicated in real time to the millions of production and distribution chains around the world standing ready to fulfill them. At the same time, those very production processes are being challenged with the problem of how to satisfy these inexhaustible wants utilizing a finite set of scarce global resources.
SCOTLAND - Results from a recent survey indicate that more than 60 per cent of slaughter pigs suffer some degree of Ileitis during their lives. The findings, collected from a comprehensive blood-testing programme carried out in Scotland, provides valuable information on the disease and how control methods could be improved.
The disease: Porcine enzootic pneumonia, caused by Mycoplasma hyopneumoniae, is one of the most prevalent diseases affecting swine production today. It can affect pigs of all ages, but infection and clinical disease normally occur during the finishing phase.
Get the latest news on Swine Health Subscribe to our newsletter